Edgewise Therapeutics, Inc. (EWTX)
Total Valuation
EWTX has a market cap or net worth of $300.92 million. The enterprise value is $37.29 million.
| Market Cap | 300.92M |
| Enterprise Value | 37.29M |
Important Dates
The latest earnings date was Thursday, May 12, 2022, before market open.
| Last Earnings Date | May 12, 2022 |
| Ex-Dividend Date | n/a |
Share Statistics
EWTX has 49.58 million shares outstanding. The number of shares has increased by 3,076.20% in one year.
| Shares Outstanding | 49.58M |
| Shares Change (YoY) | +3,076.20% |
| Shares Change (QoQ) | +32.03% |
| Owned by Insiders (%) | 1.16% |
| Owned by Institutions (%) | 114.37% |
| Float | 14.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.16 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 26.85, with a Debt / Equity ratio of 0.01.
| Current Ratio | 26.85 |
| Quick Ratio | 26.57 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -18.10%, which is considered low. The company has a ROIC of -20.00%.
| Return on Equity (ROE) | -18.10% |
| Return on Assets (ROA) | -17.50% |
| Return on Capital (ROIC) | -20.00% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.33M |
| Employee Count | 38 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (1Y) | n/a |
| Total Price Change | -79.04% |
| 50-Day Moving Average | 7.76 |
| 200-Day Moving Average | 12.94 |
| Average Volume (30 Days) | 221,441 |
Short Selling Information
The latest short interest is 3.78 million, so 7.61% of the outstanding shares have been sold short.
| Short Interest | 3.78M |
| Short % of Shares Out | 7.61% |
| Short % of Float | 26.73% |
| Short Ratio (days to cover) | 18.27 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -51.18M |
| Net Income | -50.66M |
| EBITDA | -50.34M |
| EBIT | -50.66M |
| Earnings Per Share (EPS) | -$1.02 |
Balance Sheet
The company has $265.83 million in cash and $2.20 million in debt, giving a net cash position of $263.64 million or $5.32 per share.
| Cash & Cash Equivalents | 265.83M |
| Total Debt | 2.20M |
| Net Cash | 263.64M |
| Net Cash Per Share | $5.32 |
| Book Value | 260.36M |
| Book Value Per Share | 5.25 |
| Working Capital | 258.61M |
Cash Flow
In the last 12 months, operating cash flow was -$40.02 million and capital expenditures -$975,000, giving a free cash flow of -$41.00 million.
| Operating Cash Flow | -40.02M |
| Capital Expenditures | -975,000 |
| Free Cash Flow | -41.00M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
EWTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -16.83% |
| FCF Yield | -13.62% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3,076.20% |
| Shareholder Yield | -3,076.20% |
Analyst Forecast
The average price target for EWTX is $27.29, which is 349.59% higher than the current price. The consensus rating is "Buy".
| Price Target | $27.29 |
| Price Target Difference | 349.59% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |